Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy f...

by Stine Braendegaard Winther, Pia Österlund, Åke Berglund, Bengt Glimelius, Camilla Qvortrup, Halfdan Sorbye, Per Pfeiffer, - on behalf of the Academy of Geriatric Cancer Research (AgeCare)
Published 2017-08-01

Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine—A Randomized Phase II Trial

by Alice Markussen, Lars Henrik Jensen, Laura Vittrup Diness, Finn Ole Larsen
Published 2020-07-01

Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal Cancers

by Charles A. Kunos, Stephen J. Andrews, Kathleen N. Moore, Hye Sook Chon, S. Percy Ivy
Published 2019-10-01

Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-m...

by Minami Seigo, Kijima Takashi, Shiroyama Takayuki, Okafuji Kohei, Hirashima Tomonori, Uchida Junji, Imamura Fumio, Osaki Tadashi, Nakatani Takeshi, Ogata Yoshitaka, Yamamoto Suguru, Namba Yoshinobu, Otsuka Tomoyuki, Tachibana Isao, Komuta Kiyoshi, Kawase Ichiro
Published 2013-01-01